According to The Rundown AI, University of Pennsylvania researchers applied artificial intelligence to analyze over 400,000 Reddit posts from approximately 70,000 users discussing GLP-1 medications such as Ozempic and Mounjaro, surfacing side effects that clinical trials may have underreported. As reported by The Rundown AI, the study demonstrates how large-scale natural language processing of patient-generated content can augment pharmacovigilance by flagging real-world adverse events earlier than traditional channels. According to The Rundown AI, this approach creates business opportunities for healthtech firms to build post-market safety monitoring platforms, for pharma to refine risk communication and labeling, and for payers and providers to integrate social listening signals into medication management workflows.